These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29157919)

  • 21. Stress responses of PML nuclear domains are ablated by ataxin-1 and other nucleoprotein inclusions.
    Dovey CL; Varadaraj A; Wyllie AH; Rich T
    J Pathol; 2004 Aug; 203(4):877-83. PubMed ID: 15258989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PML nuclear bodies: regulation, function and therapeutic perspectives.
    Sahin U; Lallemand-Breitenbach V; de Thé H
    J Pathol; 2014 Nov; 234(3):289-91. PubMed ID: 25138686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Body language: the function of PML nuclear bodies in apoptosis regulation.
    Hofmann TG; Will H
    Cell Death Differ; 2003 Dec; 10(12):1290-9. PubMed ID: 12934066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies.
    Sivachandran N; Sarkari F; Frappier L
    PLoS Pathog; 2008 Oct; 4(10):e1000170. PubMed ID: 18833293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New insights into the role of the subnuclear structure ND10 for viral infection.
    Tavalai N; Stamminger T
    Biochim Biophys Acta; 2008 Nov; 1783(11):2207-21. PubMed ID: 18775455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A nucleolar targeting signal in PML-I addresses PML to nucleolar caps in stressed or senescent cells.
    Condemine W; Takahashi Y; Le Bras M; de Thé H
    J Cell Sci; 2007 Sep; 120(Pt 18):3219-27. PubMed ID: 17878236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PML/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3.
    Jeanne M; Lallemand-Breitenbach V; Ferhi O; Koken M; Le Bras M; Duffort S; Peres L; Berthier C; Soilihi H; Raught B; de Thé H
    Cancer Cell; 2010 Jul; 18(1):88-98. PubMed ID: 20609355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies.
    Bernardi R; Pandolfi PP
    Nat Rev Mol Cell Biol; 2007 Dec; 8(12):1006-16. PubMed ID: 17928811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies.
    Roussigne M; Cayrol C; Clouaire T; Amalric F; Girard JP
    Oncogene; 2003 Apr; 22(16):2432-42. PubMed ID: 12717420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The PML-nuclear inclusion of human supraoptic neurons: a new compartment with SUMO-1- and ubiquitin-proteasome-associated domains.
    Villagra NT; Navascues J; Casafont I; Val-Bernal JF; Lafarga M; Berciano MT
    Neurobiol Dis; 2006 Jan; 21(1):181-93. PubMed ID: 16125395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Post-translational Modifications of PML in Regulating the Functions of Nuclear Bodies --Review].
    Ma XF; Tan Y; Li SF; Jin W; Wang KK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Oct; 27(5):1696-1700. PubMed ID: 31607334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of promyelocytic leukemia protein in host antiviral defense.
    Geoffroy MC; Chelbi-Alix MK
    J Interferon Cytokine Res; 2011 Jan; 31(1):145-58. PubMed ID: 21198351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3.
    Fu C; Ahmed K; Ding H; Ding X; Lan J; Yang Z; Miao Y; Zhu Y; Shi Y; Zhu J; Huang H; Yao X
    Oncogene; 2005 Aug; 24(35):5401-13. PubMed ID: 15940266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PML-nuclear bodies decrease with age and their stress response is impaired in aged individuals.
    Wenger B; Schwegler M; Brunner M; Daniel C; Schmidt M; Fietkau R; Distel LV
    BMC Geriatr; 2014 Apr; 14():42. PubMed ID: 24694011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are promyelocytic leukaemia protein nuclear bodies a scaffold for caspase-2 programmed cell death?
    Sanchez-Pulido L; Valencia A; Rojas AM
    Trends Biochem Sci; 2007 Sep; 32(9):400-6. PubMed ID: 17693089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PML IV/ARF interaction enhances p53 SUMO-1 conjugation, activation, and senescence.
    Ivanschitz L; Takahashi Y; Jollivet F; Ayrault O; Le Bras M; de Thé H
    Proc Natl Acad Sci U S A; 2015 Nov; 112(46):14278-83. PubMed ID: 26578773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of apoptosis by PML and the PML-NBs.
    Bernardi R; Papa A; Pandolfi PP
    Oncogene; 2008 Oct; 27(48):6299-312. PubMed ID: 18931695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation.
    Li Q; He Y; Wei L; Wu X; Wu D; Lin S; Wang Z; Ye Z; Lin SC
    Oncogene; 2011 Mar; 30(10):1194-204. PubMed ID: 21057547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The number of PML nuclear bodies increases in early S phase by a fission mechanism.
    Dellaire G; Ching RW; Dehghani H; Ren Y; Bazett-Jones DP
    J Cell Sci; 2006 Mar; 119(Pt 6):1026-33. PubMed ID: 16492708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PML nuclear bodies and apoptosis.
    Takahashi Y; Lallemand-Breitenbach V; Zhu J; de Thé H
    Oncogene; 2004 Apr; 23(16):2819-24. PubMed ID: 15077145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.